Location of Repository

The safety and effectiveness of different methods of ear wax removal: a systematic review and economic evaluation

By A. Clegg, E. Loveman, E. Gospodarevskaya, P. Harris, A. Bird, J. Bryant, D.A. Scott, P. Davidson, P. Little and R. Coppin

Abstract

Ear wax (cerumen) is a natural secretion produced to protect the inner ear from dirt and other fragments by moving these particles towards the outer ear. If this process does not happen properly, wax may build up causing blockage in the ear canal and the possibility of impaction. People with a build up of ear wax may suffer from hearing loss, discomfort and, on occasions, infection. It may present problems in assessing hearing, blocking the view of the ear drum during medical examination and interfering with the fitting or function of hearing aids. Although it is thought to affect between 2% and 6% of the population in the England and Wales, some groups may be at a higher risk, such as those using hearing aids or with small ear canals and/or skin conditions. Recurrence is thought to be high among some of these groups. The consequences of the build up of ear wax in the ear canal are thought to be a common reason for consultation and cost in general practice with over 2 million consultations per year in the NHS.<br/><br/>Methods of removal of ear wax include drops, flushing with water in general practice, and removal with suction or probes in specialist clinics. The relative safety and benefits of these different methods of removal remains uncertain. This research will systematically review published and unpublished evidence on the clinical and cost effectiveness of different methods for the removal of ear wax. Where appropriate, it will develop an economic model using data from this systematic review and other relevant sources to estimate the relative costs and benefits of different methods. In addition, the project will provide recommendations for future research to try to help answer any remaining areas of uncertainty

Topics: RF
Year: 2010
OAI identifier: oai:eprints.soton.ac.uk:153113
Provided by: e-Prints Soton
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://dx.doi.org/10.3310/hta1... (external link)
  • Suggested articles

    Citations

    1. (2002). [Evaluation of cerumenolytic efficacy of Audispray.] Otorinolaringologia
    2. (2001). 1 Clinical and cost-effectiveness of donepezil, rivastigmine and galantamine for Alzheimer’s disease: a rapid and systematic
    3. A cost-effectiveness analysis of earwax softeners.
    4. A new ceruminolytic agent in clinical use:
    5. (1999). A review by
    6. (2002). A study of the methods used to select review criteria for clinical audit. By Hearnshaw
    7. (2008). A systematic review and economic model of switching from nonglycopeptide to glycopeptide antibiotic prophylaxis for surgery. By Cranny
    8. (2000). Assessment reports published to date 166Volume 4,
    9. (2010). Assessment reports published to date 186Health Technology Assessment programme
    10. (2007). Calculating partial expected value of information via Monte Carlo sampling algorithms. Med Decis Making doi
    11. (2010). Cerumen removal: how necessary is it to diagnose acute otitis media. Am J Dis Child 137:1064–65.DOI: 10.3310/hta14280 Health Technology Assessment
    12. (2010). Chronic tinnitus resulting from cerumen removal procedures. Int Tinnitus J 2004;10:42–6.DOI: 10.3310/hta14280 Health Technology Assessment
    13. Clinical trial of a ceruminolytic agent in general practice. doi
    14. (2009). Deferasirox for the treatment of iron overload associated with regular blood transfusions (transfusional haemosiderosis) in patients suffering with chronic anaemia: a systematic review and economic evaluation. By McLeod doi
    15. (2001). Docusate sodium with irrigation was better than triethanolamine polypeptide with irrigation for dissolving earwax. Evid Based Nurs doi
    16. Does irrigation of the ear to remove impacted wax improve hearing? doi
    17. (2009). Ear drops for the removal of ear wax. Cochrane Database of Systematic Reviews doi
    18. Ear drops for the removal of earwax. doi
    19. (2003). Ear syringing improved hearing in general practice. Evid Based Nurs doi
    20. Effect of cerumen removal on the hearing ability of geriatric patients. doi
    21. Expected value of information and decision making in HTA. doi
    22. How does liquid docusate sodium (Colace) compare with triethanolamine polypeptide as a ceruminolytic for acute earwax removal?
    23. (2003). How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Empirical
    24. In pursuit of ceruminolytic agents: a study of earwax composition. doi
    25. (2010). inadequate, partial, reported, not reported, unclear.DOI: 10.3310/hta14280 Health Technology Assessment
    26. (1975). inadequate, partial, reported, unknown.Appendix 3 116 Amjad and Scheer51 Extracted by: PH Checked by: EL Reference and design Intervention Participants Outcome measures Author: Amjad and Scheer51 Year:
    27. (1982). inadequate, partial, reported, unknown.Appendix 3 120 Fahmy and Whitefield54 Extracted by: EL Checked by: AC Reference and design Intervention Participants Outcome measures Author: Fahmy and Whitefield54 Year:
    28. (2001). inadequate, partial, reported, unknown.Appendix 3 126 Carr and Smith52 Extracted by: EL Checked by: AC Reference and design Intervention Participants Outcome measures Author: Carr and Smith52 Year:
    29. (1992). inadequate, partial, reported, unknown.Appendix 3 128 Lyndon and colleagues45 Extracted by: EL Checked by: AC Reference and design Intervention Participants Outcome measures Author: Lyndon and colleagues45 Year:
    30. (2006). inadequate, partial, reported, unknown.Appendix 4 146 Pothier and colleagues56 Extracted by: AC Checked by: PH Reference and design Intervention Participants Outcome measures Author: Pothier and colleagues56 Year:
    31. (2005). inadequate, partial, reported, unknown.Appendix 4 148 Saloranta and colleagues58 Extracted by: EL Checked by: AC Reference and design Intervention Participants Outcome measures Author: Saloranta and colleagues58 Year:
    32. (2008). inadequate, partial, reported, unknown.Appendix 5 154 Coppin and colleagues63 Extracted by: AC Checked by: PH Reference and design Intervention Participants Outcome measures Author: Coppin and colleagues63 Year:
    33. (2010). inadequate, partial, reported, unknown.DOI: 10.3310/hta14280 Health Technology Assessment
    34. (1992). inadequate, partial, reported, unknownAppendix 3 118 Dummer and colleagues44 Extracted by: EL Checked by: PH Reference and design Intervention Participants Outcome measures Author: Dummer and colleagues44 Year:
    35. (1997). Methods for the economic evaluation of health care programmes.
    36. Modelling payback from research into the efficacy of left-ventricular devices. doi
    37. (2010). No. 1 Multicentre randomised controlled trial examining the cost-effectiveness of contrast-enhanced high field magnetic resonance imaging in women with primary breast cancer scheduled for wide local excision doi
    38. (2007). No. 1 Pemetrexed disodium for the treatment of malignant pleural mesothelioma: a systematic review and economic
    39. (2005). No. 1 Randomised controlled multiple treatment comparison to provide a costeffectiveness rationale for the selection of antimicrobial therapy in acne.
    40. (2010). Queen’s Printer and Controller of HMSO. All rights reserved. 165No. 15 Ethical issues in the design and conduct of randomised controlled trials. A review by
    41. (2010). Queen’s Printer and Controller of HMSO. All rights reserved. 167No. 31 A randomised controlled trial of prehospital intravenous fluid replacement therapy in serious trauma. By
    42. (2010). Queen’s Printer and Controller of HMSO. All rights reserved. 169No. 15 A systematic review of the effectiveness and cost-effectiveness of metal-onmetal hip resurfacing arthroplasty for treatment of hip disease.
    43. (2010). Queen’s Printer and Controller of HMSO. All rights reserved. 171No. 35 Systematic review and economic decision modelling for the prevention and treatment of influenza A doi
    44. (2010). Queen’s Printer and Controller of HMSO. All rights reserved. 173No. 46 Supplementation of a home-based exercise programme with a classbased programme for people with osteoarthritis of the knees: a randomised controlled trial and health economic analysis. doi
    45. (2010). Queen’s Printer and Controller of HMSO. All rights reserved. 175No. 48 Systematic review of effectiveness of different treatments for childhood retinoblastoma. doi
    46. (2010). Queen’s Printer and Controller of HMSO. All rights reserved. 177No. 49 A systematic review and economic model of the clinical and costeffectiveness of immunosuppressive therapy for renal transplantation in children. By
    47. (2010). Queen’s Printer and Controller of HMSO. All rights reserved. 179No. 50 Evaluation of diagnostic tests when there is no gold standard. A review of methods. By Rutjes
    48. (2010). Queen’s Printer and Controller of HMSO. All rights reserved. 181No. 12 Improving the evaluation of therapeutic interventions in multiple sclerosis: the role of new psychometric methods. By
    49. (2010). Queen’s Printer and Controller of HMSO. All rights reserved. 183Rivaroxaban for the prevention of venous thromboembolism: a single technology appraisal.
    50. (2010). Queen’s Printer and Controller of HMSO. All rights reserved. 185Topotecan for the treatment of recurrent and stage IVB carcinoma of the cervix. doi
    51. Randomized clinical trial of docusate, triethanolamine polypeptide, and irrigation in cerumen removal in children. doi
    52. (2010). Research in progress: National Research Register
    53. Review of guidelines for good practice in decision-analytic modelling in health technology assessment. doi
    54. (2001). Systematic reviews in health care: meta analysis in context. doi
    55. (2007). Technol Assess Health Care doi
    56. (2006). The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer’s
    57. The half-life of truth: what are appropriate time horizons for research decisions? Medical Decision Making. Med Decis Making 2008;3:287–99. doi
    58. The most effective products available to facilitate ear syringing. doi
    59. (2006). Unit costs of health and social care.
    60. (2002). Valutazione dell’efficacia cerumenolitica di Audispray. Otorinolaringol
    61. (1999). Warmed versus room temperature saline solution for ear irrigation: a randomized clinical trial. Ann Emerg Med doi
    62. (2010). Waxsol (n = 47) Cerumol (n = 60) p-value AEs,
    63. (2004). What is the best imaging strategy for acute stroke? By

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.